Drug resistance and the treatment of upper respiratory infections

American Journal of Managed Care

Volumn 5, Issue SUPPL. 15, 1999, Pages

  Bishai, William R ^a,b   Chaisson, Richard E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; MULTIPLE CHOICE TEST; PRIORITY JOURNAL; UPPER RESPIRATORY TRACT INFECTION;

EID: 0033381663     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Poole MD. A focus on acute sinusitis in adults: Changes in disease management. Am J Med 1999;106:38S-47S.
2. Godofsky E, Zinreich J, Armstrong M, et al. Sinusitis in HIV-infected patients. A clinical and radiographic review. Am J Med 1992;93:163-170.
3. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations. JAMA 1995;273:957-960.
4. Doern GV, Pfaller MA, Kugler K, Freeman J, Jones RN. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis 1998;27(4):764-770.
5. Centers for Disease Control and Prevention. Geographic variation in penicillin resistance in Streptococcus pneumoniae - selected sites. United States, 1997. Mort Morb Week Rep CDC Surveill Summ 1999;48:656-661.
6. Butler JC, Jofmann J, Cetron MS, et al. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996;174:986-993.
7. Jacobs MR. Drug-resistant Streptococcus pneumoniae: Rational antibiotic choices. Am J Med 1999;106(5A):19S-25S.
8. Fenoll A, Bourgon C, Munoz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis 1991;13:56-60.
9. Marton A, Gulyas M, Munoz R, Tomasz A. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis 1991;163:542-548.
10. Friedland IR, Klugman KP. Penicillin-resistant pneumococcal infections in South African children. Am J Dis Child 1992;146:920-923.
11. Doern GV, Brueggemann A, Holley HP, Jr., Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40(5):1208-1213.
12. Thornsberry C, Ogilvie P, Kahn J, et al. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in the 1996-1997 respiratory season: The Laboratory Investigator Group. Diagn Microbiol Infect Dis 1997;29:247-257.
13. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance System. N Engl J Med 1999;341:233-239.
14. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333(8):481-486.
15. Tomasz A. Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis 1997;24(suppl 1):S85-S88.
16. Doern GV, Brueggemann AB, Blocker M, et al. Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States. Clin Infect Dis 1998;27(4):757-761.
17. Novak R, Henriques B, Charpentier E, Normark S, Tuomanen E. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 1999;399(6736):590-593.
18. Tomasz A. The pneumococcus at the gates. N Engl J Med 1995;333:514-515.
19. Shortridge D, Doern C, Beyer J, Brueggemann A, Flamm RK. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae. Presented at the meeting of the Infectious Diseases Society of America, Denver, CO, November 12-15, 1998 [abstract].
20. Craft JC, Notario G, Hom R, Shortridge D, Flamm RK. Can erythromycin resistant Streptococcus pneumoniae be treated with a macrolide? Presented at the meeting of the Infectious Diseases Society of America, Denver, CO, November 12-15, 1998 [abstract].
21. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J 1995;14(10):885-890.
22. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333(8):474-480.
23. Plouffe JF, Breiman RF, Facklam RR, Franklin County Pneumonia Study Group. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. JAMA 1996;275(3):194-198.
24. Rahav G, Toledano Y, Engelhard D, et al. Invasive pneumococcal infections. A comparison between adults and children. Medicine (Baltimore) 1997;76(4):295-303.
25. Jacobs MR. Antibiotic-resistant Streptococcus pneumoniae in acute otitis media: Overview and update. Pediatr Infect Dis J 1998;17(10):947-952.
26. Gehanno P, N'Guyen L, Derriennic M, Pichon F, Goehrs JM, Berche P. Pathogens isolated during treatment failures in otitis. Pediatr Infect Dis J 1998;17(10):885-890.
27. Dagan R, Leibovitz E, Greenberg D, Yagupsky P, Fliss DM, Leiberman A. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J 1998;17(10):880-885.
28. Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J 1996;15(11):980-985.
29. Conte JE Jr, Golden JA, Duncan S, McKenna E, Zurlinden E. Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin. Antimicrob Agents Chemother 1995;39(2):334-338.
30. Patel KB, Xuan D, Tessier PR, Russomanno JH, Quintiliani R, Nightingale CH. Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. Antimicrob Agents Chemother 1996;40(10):2375-2379.